ASH 2017 | May the force be with you: the power of next-generation sequencing
Clinical access to new technologies, such as next-generation sequencing (NGS), can revolutionize the treatment of cancer. In this interview, Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, eloquently highlights the potential of NGS for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Dr Garcia-Manero emphasizes the power of this tool for predictive screening, among a range of other utilities. This video was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.
Get great new content delivered to your inboxSign up